CD274 and neoplasm: Both P47 and S47 TBM treated with anti-PD-L1 demonstrated tumor growth reduction when compared with genotype-matched isotype-treated controls, and when the increased growth rate of tumors in S47 hosts was taken into account, the overall fold decrease in tumor growth in P47 and S47 mice appeared similar (Fig. 7A).